Panakeia
About Panakeia
Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer.
Founded in 2018 and headquartered in London, England, Panakeia specializes in software development with a focus on machine learning, deep learning, artificial intelligence, cancer diagnostics, and personalized medicine.
Mission and Goals
Panakeia is dedicated to revolutionizing cancer diagnostics by delivering rapid, instrument-free precision cancer diagnostic solutions using their AI platform PANProfiler, which transforms routine tissue samples into detailed molecular insights in minutes instead of days. Their technology aims to improve hospital efficiency, accelerate pharmaceutical discovery and development, and provide patients with faster and more targeted treatment options.